AstraZeneca
The Executive Director, AI for Discovery leads AstraZeneca’s strategy to apply advanced AI and machine learning to accelerate oncology and biopharmaceutical discovery. This senior leader guides a global, cross‑functional AI capability, partnering with discovery biology, chemistry, translational medicine, and therapeutic area leadership to embed AI‑enabled insights across the entire discovery pipeline.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
9% above the average for this role
Senior AI Scientist – Drug Discovery & Computational Biology (Hybrid - Boston, MA, USA)
OMGTech
Chief Scientist, Modern Drug Discovery
lifelancer
Chief Scientist, Modern Drug Discovery
lifelancer
Chief Scientist, Modern Drug Discovery
IQVIA
Chief Scientist, Modern Drug Discovery
lifelancer
Scientist, Integrated Computational and Experimental Inflammation Discovery
Amgen